PropertyValue
?:abstract
  • Recommendation provides information to employees of medical departments at any level and primarily primary care about the possible proarrhythmic and adverse effects of drugs used for the treatment of COVID-19 patients and the features of therapy for COVID-19 patients with heart rhythm and conduction disorders receiving permanent antiarrhythmic therapy.
is ?:annotates of
?:creator
?:doi
  • 10.18087/cardio.2020.10.n1283
?:doi
?:journal
  • Kardiologiia
?:license
  • unk
?:pmid
?:pmid
  • 33228499.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • [Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy.]
?:type
?:year
  • 2020-09-16

Metadata

Anon_0  
expand all